We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Christoph Wanner

Christoph Wanner MD

Professor of Medicine; Chief of the Division of Nephrology and Hypertension, University Hospital of Würzburg, Germany

Christoph Wanner, M.D., is Professor of Medicine and Chief of the Division of Nephrology and Hypertension at the University Hospital of Würzburg, Germany.

Dr. Wanner’s areas of interest are metabolic disorders and cardiovascular outcomes in patients with diabetic kidney and other rare diseases. He has served as the principal investigator of the 4D Study and as a steering committee member and central European coordinator of the SHARP Study. He has published more than 500 pubmed referenced scientific articles. He serves as editor-in-chief for the Journal of Renal Nutrition as well as subject editor and member of the editorial review boards of many other journals. Dr. Wanner is an executive officer of KDIGO (Kidney Disease Improving Global Outcomes) and co-chair of several guideline work group and controversy conferences. Until recently C. Wanner was chair of the European Renal Registry of the ERA-EDTA (2009-2015). In 2007 he received the International Distinguished Medal of the National Kidney Foundation. Dr. Wanner is a honorary member of the Polish Society of Nephrology and received a doctor honoris causa from the Charles University Prague in 2012.